Download PDF
Thromb Haemost 1997; 78(05): 1419-1420
DOI: 10.1055/s-0038-1665424
Letter to the Editor
Schattauer GmbH Stuttgart

A Novel Polymorphism in Exon 10 of the Factor V Gene Inducing an Amino Acid Replacement of Arginine to Lysine at Codon 485

Tetsuo Ozawa
The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan
,
Kenji Niiya
The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan
,
Naoko Ejiri
The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan
,
Nobuo Sakuragawa
The Department of Clinical Laboratory Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Toyama City, Japan
› Author Affiliations
Further Information

Publication History

Received 26 1997

Accepted after resubmission 09 July 1997

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlbäck B, Carlsson MS, vensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedSearch in Google Scholar
  • 2 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Driven RJ, de Ronde, van derVeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedSearch in Google Scholar
  • 3 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
    CrossrefPubMedSearch in Google Scholar
  • 4 Takamiya O, Ishida F, Kodaira H, Kitano K. APC resistance and the Mnl I genotype (Gln506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Ozawa T, Niiya K, Sakuragawa N. Absence of factor V Leiden in the Japanese. Thromb Res 1996; 81: 595-596
    CrossrefPubMedSearch in Google Scholar
  • 6 Shen NL, Fan ST, Pyati J, Graff R, LaPolla RJ, Edgington TS. The serine protease cofactor facto V is synthesized by lymphocytes. J Immunol 1993; 150: 2992-3001
    PubMedSearch in Google Scholar
  • 7 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361-1362
    PubMedSearch in Google Scholar
  • 8 Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-4850
    CrossrefPubMedSearch in Google Scholar
  • 9 Kane WH, Davie EW. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci USA 1986; 83: 6800-6804
    CrossrefPubMedSearch in Google Scholar
  • 10 Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 1987; 26: 6508-6514
    CrossrefPubMedSearch in Google Scholar
  • 11 Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-3785
    CrossrefPubMedSearch in Google Scholar